Sovran Advisors, LLC Sarepta Therapeutics, Inc. Put Options Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
479Shares Held
89.5MCall Options Held
1.41MPut Options Held
1.19M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$166 Million0.12% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.5 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...